Publicaties

Kamal RM, Schellekens A, DeJong CA, Dijkstra BAG.  2015.  Baclofen as relapse prevention in the treatment of Gamma- Hydroxybutyrate (GHB) dependence: an open label study.. BMC Psychiatry. 15:91.

Kamal RM, Loonen AJ, Dijkstra BAG, DeJong CA.  2015.  Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate dependence: a case series.. J Clin Psychopharmacol. 35(3):313-8.

Kisjes H., Verbrugge C, DeJong CA.  2015.  Begeleiding en behandeling bij verslavingsproblematiek. Psychiatrie voor verpleegkundigen. :253-273.

Emmelkamp P.M.G., Merkx M.JM, De Fuentes-Merillas L.  2015.  Contingency Management. Gedragstherapie. 48(2):153-170.

Domínguez I, Bruguera P, Balcells-Oliveró M, Batalla A.  2015.  Depression Following γ-Hydroxybutyrate Withdrawal: A Case Report.. J Clin Psychopharmacol.

Ayu AParawita, Schellekens A, Iskandar S, Pinxten L, DeJong CA.  2015.  The development of an National Training Program on Addiction Medicine in Indonesia. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. XII

Ter Huurne ED, de Haan HA, Napel-Schutz MC ten, Postel MG, Menting J, van der Palen J, Vroling MS, DeJong CA.  2015.  Is the Eating Disorder Questionnaire-Online (EDQ-O) a valid diagnostic instrument for the DSM-IV-TR classification of eating disorders? Comprehensive Psychiatry. 57

El-Guebaly N., DeJong CA.  2015.  Education and Training: An Introduction. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. XII:2377-2379.

Burger DM, De Mast Q, Schellekens A.  2015.  Efavirenz en risico op zelfmoord bij hiv-patiënten. Ned Tijdschr Geneeskd. 159

Ayu AParawita, Schellekens A, Iskandar S, Pinxten L, DeJong CA.  2015.  Effectiveness and Organization of Addiction Medicine Training Across the Globe.. Eur Addict Res. 21(5):223-39.

Markus W, Hornsveld H.  2015.  EMDR en verslaving. Praktijkboek EMDR, deel II. Toepassingen voor nieuwe patientengroepen en stoornissen..

Rietveld J, Hoek T, van Beek M, Schellekens A.  2015.  Familial liability for metoprolol-induced psychosis. General Hospital Psychiatry. 37(6):Pages620.e5–620.e6.

Mothapo KM, Schellekens A, Van Crevel R, Keuter M, Grintjes-Huisman K, Koopmans P, van der Ven A.  2015.  Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment. CNS & Neurological Disorders - Drug Targets. 14(6):811-818(8).

Qurishi R., Arts-DeJong M., Franzek E.J., Hartman L., DeJong CA.  2015.  Influence of Premenstrual Syndrome on Relapse in Nicotine Abuse a Case Report. Austin Journal of Drug Abuse and Addiction. 2(1)

de Haan L, de Haan HA, DeJong CA.  2015.  Interpersonal relating, risk-taking behavior and alcohol use in young adults. Relating Theory - Clinical and Forensic Applications.

Goveia J, van Oene GH de Weert, Hoevenaars G, de Leeuw R, Schrijvers AJP.  2015.  Kicks United; Rolmodellen en beloningen ter verbetering van therapietrouw bij jonge verslaafden. Verslaving.

De Fuentes-Merillas L, van Mil N., de Hart A..  2015.  Klinisch beeld en behandeling van problematisch internetgebruik en gameverslaving. Internet Verslaving. :149-162.

van Oene GH de Weert, Gongora V, von Sternberg K, DeJong CA.  2015.  Motivation for Treatment and Motivation for Change in Substance-Dependent Patients with Co-Occurring Psychiatric Disorders. Journal of Psychoactive Drugs. 47(5):393-400.

Markus W, van Oene GH de Weert, Becker ES, DeJong CA.  2015.  A multi-site randomized study to compare the effects of Eye Movement Desensitization and Reprocessing (EMDR) added to TAU versus TAU to reduce craving and drinking behavior in alcohol dependent outpatients: study protocol.. BMC Psychiatry. 15:51.

Binelli C, Muñiz A, Sanches S, Ortiz A, Navines R, Egmond E, Udina M, Batalla A, López-Sola C, Crippa JA et al..  2015.  New evidence of heterogeneity in social anxiety disorder: defining two qualitatively different personality profiles taking into account clinical, environmental and genetic factors. Eur Psychiatry. 30(1):160-5.

Paling E.P., Dijkstra BAG, DeJong CA, Schellekens A.  2015.  Prevalentie en behandeling van benzodiazepineverslaving. Tijdschrift Gedragstherapie. 48(2):185-198.

de Haan HA, DeJong CA.  2015.  Psychoactieve middelen. Diagnose en Therapie 2015-2016.

Joosten EAG, Jaspers J, Dijkstra BAG, DeJong CA.  2015.  Samen beslissen in de ggz en verslavingszorg. Nederlands tijdschrift voor evidence based practice. 3:18-20.

Kok T, de Haan HA, Wieske E, van Oene GH de Weert, DeJong CA.  2015.  Screening For Personality Disorders in Outpatient Substance Use Disorder Patients. European Journal of Psychological Assessment.

Kok T, de Haan HA, van der Meer M, Najavits LM, DeJong CA.  2015.  Screening of current post-traumatic stress disorder in patients with substance use disorder using the Depression, Anxiety and Stress Scale (DASS-21): a reliable and convenient measure.. Eur Addict Res. 21(2):71-7.